Yeo Ji-In, Lee Rangyeon, Kim Haneul, Ahn Somin, Park Jeongho, Sung Haan Woo
College of Veterinary Medicine, Kangwon National University, Chuncheon, Republic of Korea.
Multidimensional Genomics Research Center, Kangwon National University, Chuncheon, Republic of Korea.
Heliyon. 2023 Sep 9;9(9):e19860. doi: 10.1016/j.heliyon.2023.e19860. eCollection 2023 Sep.
Fowl adenovirus 4 (FAdV-4) is a major avian virus that induces fatal diseases in chicken such as, hydropericardium and hepatitis. The viral structure consists of hexon, penton, fiber-1, and fiber-2 which are associated with immunopathogenesis. In this study, we investigated the genetic modification of a FAdV-4 strain after continuous passages in a cell line and evaluated the pathogenicity associated with mutations. We used the FadV-4 KNU14061 strain, which was isolated from layers in 2014. The virus went through 80 passages in the Leghorn male hepatoma (LMH) cell line. The full genetic sequence was identified, and we found a frameshift in the fiber-2 amino acid sequence after the initial thirty passages. To examine whether the frameshift in the fiber-2 gene affects the pathogenicity in chicken, we inoculated LMH80 (80 times passaged) and LMH10 (10 times passaged) into 3-day-old chickens and examined the pathogenesis. LMH10 infection via intramuscular route induced fatal pathology, but LMH80 did not. Furthermore, LHM80 pre-treatment protected hosts from the LMH10 challenge. Thus, the genetic modification isolated by serial passage lowered pathogenicity and the resulting virus acted as an attenuated vaccine that can be a FAdV-4 vaccine strain candidate.
禽腺病毒4型(FAdV-4)是一种主要的禽类病毒,可在鸡中引发致命疾病,如心包积水和肝炎。病毒结构由六邻体、五邻体、纤维-1和纤维-2组成,这些与免疫发病机制相关。在本研究中,我们调查了FAdV-4毒株在细胞系中连续传代后的基因修饰情况,并评估了与突变相关的致病性。我们使用了2014年从蛋鸡中分离出的FadV-4 KNU14061毒株。该病毒在来航鸡雄性肝癌(LMH)细胞系中传代了80次。确定了完整的基因序列,我们发现在最初30次传代后纤维-2氨基酸序列中出现了移码突变。为了检查纤维-2基因中的移码突变是否影响鸡的致病性,我们将传代80次的LMH(LMH80)和传代10次的LMH(LMH10)接种到3日龄鸡中,并检查发病机制。通过肌肉注射途径感染LMH10会导致致命病变,但LMH80不会。此外,用LHM80预处理可保护宿主免受LMH10的攻击。因此,通过连续传代分离出的基因修饰降低了致病性,所得病毒可作为一种减毒疫苗,有望成为FAdV-4疫苗株候选。